5. materials and methods -...
Post on 11-May-2020
4 Views
Preview:
TRANSCRIPT
Materials and Methods
34
5. MATERIALS AND METHODS
5.1. Collection and authentication of plant materials
The plants Phyllanthuspolyphyllus&Prosopis cinerariawere collected in the
month of November 2009 from the Kolli hills and around in Salem District,
Tamilnadu, India. The plant material was taxonomically identified by the Botanical
Survey of India, Coimbatore, Tamil Nadu.
Preparation of extracts
The leaves of Phyllanthuspolyphyllus&Prosopis cineraria were dried under
shade and then powdered with a mechanical grinder. The powder was passed
through sieve No 40 and stored in an airtight container for further use.
Chemicals
Petroleum Ether (60-80o C), Methanol (95% v/v)
Extraction procedure
Petroleum Ether
The coarse powder was extracted with 1-1.5 liters of Pet. Ether (60-80o C) by
continuous hot percolation using Soxhlet apparatus. After the completion of
extraction, it was filtered and the solvent was removed by distillation under reduced
pressure.
Methanol extract
The marc left after Pet. ether extraction was dried and extracted with 1-1.5
liters of methanol (70-80oC) by continuous hot percolation using Soxhlet apparatus.
Materials and Methods
35
After the completion of extraction, it was filtered and the solvent was removed by
distillation under reduced pressure. The extract was stored in desiccator. The
extractive values are presented in table 3.
Table 3.\Data showing the Extractive Values of Leaves of Phyllanthuspolyphyllus &
Prosopis cineraria.
Plant Name Part used Method ofExtraction
Yield in percentage(w/w)
PetroleumEther Methanol
Phyllanthuspolyphyllus Leaves Continuous hot percolation 4.5 5.2
Prosopis cineraria Leaves Continuous hot percolation 3.5 4.2
5.2. PRELIMINARY PHYTOCHEMICAL STUDIES [117-120]
Test for Carbohydrates and Glycosides
A small quantity of the extracts were dissolved separately in 4 ml of distilled
water and filtered. The filtrate was subjected to Molisch’s test to detect the presence
of Carbohydrates.
Molisch's Test
Filtrate was treated with 2-3 drops of 1% alcoholic - napthol solution and 2
ml of Con sulfuric acidwas added along the sides of the test tube. Appearance of
brown ring at the junction of two liquids shows the presence of carbohydrates.
Another portion of the extract was hydrolysed with hydrochloric acid for few
hours on a water bath and the hydrolysate was subjected to Legal’s and Borntrager’s
test to detect the presence of different glycosides.
Materials and Methods
36
Legal’s Test
To the hydrolysate 1 ml of pyridine and few drops of sodium nitroprusside
solutions were added and then it was made alkaline with sodium hydroxide solution.
Appearance of pink to red colour shows the presence of glycosides.
Borntrager’s Test
Hydrolysate was treated with chloroform and then the chloroform layer was
separated. To this equal quantity of dilute ammonia solution was added. Ammonia
layer acquires pink color, showing the presence of glycosides.
Test for Alkaloids
A small portion of the solvent free pet ether, alcohol extracts were stirred
separately with few drops of diluted hydrochloric acid and filtered. The filtrate was
tested with various reagents for the presence of alkaloids.
Mayer’s reagent - Cream precipitate
Dragendroff’s reagent - Orange brown precipitate
Hager’s reagent - Yellow precipitate
Wagner’s reagent - Reddish brown precipitate
Test for Phytosterol
The extracts were refluxed with solution of alcoholic potassium hydroxide
till complete saponification has taken place. The mixture was diluted and extracted
with ether. The ether layer was evaporated and the residue was tested for the
presence of Phytosterol.
Materials and Methods
37
Liebermann Burchard Test
The residue was dissolved in few drops of dilutedaceticacid, 3 ml of acetic
anhydride was added followed by few drops of concentratedsulphuric acid.
Appearance of bluish green colour shows the presence of Phytosterol.
Tests for Fixed Oils
Spot Test
Small quantities of various extracts were separately pressed between two
filter papers. Appearance of oil stain on the paper indicates the presence of fixed oil.
Few drops of 0.5N alcoholic potassium hydroxide were added to a small quantity of
various extracts along with a drop of phenolphthalein. The mixture was heated on a
water bath for 1-2 hours. Formation of soap or partial neutralization of alkali
indicates the presence of fixed oils and fats.
Test for Gums and Mucilages
Small quantities of the extracts were added separately to 25 ml of absolute
alcohol with constant stirring and filtered. The precipitate was dried in air and
examined for its swelling properties for the presence of carbohydrates.
Test for Saponins
The extracts were diluted with 20 ml of distilled water and it was agitated in
a graduated cylinder for 15 minutes. The formation of 1 cm layer of foam shows the
presence of Saponins.
Test for Proteins and Free Amino Acids
Small quantities of the extracts were dissolved in few ml of water and treated
with following reagents. a. Million’s reagent-Appearance of red color shows the
Materials and Methods
38
presence of protein and free amino acid. b. Ninhydrin reagent- Appearance of
purple colourshowsthe presence of proteins and free amino acids. c. Biuret test-
Equal volumes of 5% sodium Hydroxide solution & 1% copper sulphate solution
was added. Appearance of pink or purple color Shows the presence of proteins and
free amino acids.
Test for Phenolic Compounds and Tannins
Small quantities of the extracts were taken separately in water and tested for
the presence of phenolic compounds and tannins were carried out with the following
reagents.
1. Dil Ferric chloride solution (5%) – Violet color.
2. 1% solution of gelatin containing 10% sodium chloride-White precipitate
3. 10% lead acetate solution-White precipitate
Test for Flavonoids
1. with Aqueous Sodium Hydroxide Solutions
Blue to violet colour (anthocyanins) yellow colour (flavones), yellow to
orange (flavonones)
2. with Sulphuric Acid
Yellow orange colour (anthocyanins) yellow to orange colour (flavones)
orange to crimson (flavonones)
3. Shinoda’s Test
Small quantities of the extracts were dissolved in alcohol, to them piece of
magnesium followed by Con: hydro chloric acid drop wise added and heated.
Materials and Methods
39
Appearance of magenta color shows the presence of flavonoids. The results of
phytochemical test are presented in table 4 & 5.
5.3. INVITRO CYTOTOXICITY STUDIES
Tissue culture has been used to screen many anticancer drugs, as there is
clear correlation between the in vitro and in vivo activities of potential
chemotherapeutic agents. There is scientific justification for cytotoxicity testing in
tissue culture, since animal models are in many ways inadequate for predicting the
effects of chemicals on humans since there are many metabolic differences between
species. Cytotoxicity studies involve the analysis of morphological damage or
inhibition of zone of outgrowth induced by the chemicals tested (Table 6).
Assay for Proliferation Studies
5.3.1. Trypan blue dye exclusion assay [121]
Principle
Trypan blue is a vital stain used to selectively colour dead tissues or cells
blue. It is a diazo dye. Trypan blue is recommended in dye Exclusion procedures for
viable cell counting based on the principle that live (viable) cells actively pump out
the dye by efflux mechanism where as dead (non-viable) cells do not. So in this
assay white transparent cells are viable cells and blue cells taking up the dye are
dead cells.
Cell line used: HepG2 - Human Liver Cancer cells
Procedure:
1. Cell suspension was prepared in a medium.
Materials and Methods
40
2. Transferred 700 l of a cell suspension to 24 well plate and incubate 24 hrs
in 5% CO2. After incubation add 300 l of drug with varying concentration
of MPP & MPC (62.5-1000 g/ml) and incubate 48 h.
3. 100 l of cell suspension was taken and added 100 l of 0.4% Trypan Blue
Solution to anEppendorf tube and mixed thoroughly. Allowed to stand for 5
to 15 minutes.
4. With the cover-slip in place, using a Pasteur pipette transferred a small
amount of trypan blue-cell suspension mixture to both chambers of a
hemocytometer. Carefully touched the edge of the cover-slip with the pipette
tip and allowed each chamber to fill by capillary action.
5. Starting with chamber 1 of the hemocytometer, counted all the cells in the 1
mm center square and four 1 mm corner squares. Non-viable cells stainedand
appeared in blue color. Viable and non-viable cells were counted separately.
Calculation
Number of non viable cells (Stained)% Inhibition = ------------------------------------------------- X 100
Total Cells (Stained and Unstained)
5.3.2. MTT (3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide)
method
Materials for MTT assay
RPMI-1640 media (Himedia, Mumbai, India)
Fetal bovine serum (Gibco’s, USA)
Penicillin-G (Himedia, Mumbai, India)
Materials and Methods
41
Streptomycin (Himedia, Mumbai, India)
Amphotericin-B
Phosphate buffered saline (PBS) (Himedia, Mumbai, India)
Trypsin (Trypsin-EDTA [1x] in HBSS, Gibco’s UK)
Ethylenediamine tetra-acetic acid (EDTA) (Himedia, Mumbai, India)
Trypan blue (Himedia, Mumbai, India)
Dimethyl sulphoxide (DMSO) (Merck India Ltd, Mumbai, India)
SDS lysis buffer (Himedia, Mumbai, India)
MTT (3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide) (Himedia,
Mumbai, India)
Additional equipments required
CO2 incubator (WTC Binder, Germany)
Laminar air flow cabin (Klenzaids, Chennai, India)
Refrigerated centrifuge (Biofuge Fresco, by Heraeus, Germany)
ELISA-reader (for MTP) (Anthos 2010, Germany)
Deep freezer (Polar Angelantoni Industries, Italy)
Ultrasonic bath (Transonic [460/H], by Elma®, Germany)
Vaccum pump (Zenith [model: PDF-2-2.5], Mumbai, India)
Pipettes (Eppendorf, Hamburg, Germany)
Culture plates (Felcon, Germany)
Centrifuge tubes (Felcon, Germany)
Materials and Methods
42
Eppendorf tubes (Tarsons, Mumbai, India)
Aerosol resistant tips (Tarsons, Mumbai, India)
Flat-bottomed 96-well MTP, tissue culture grade (Tarsons, Mumbai, India)
Procedure
Preparation of antibiotic solutions
Penicillin-G
1 0.61 g (one vial) of penicillin-G was weighed and dissolved in 1 ml of sterile
phosphate buffered saline (PBS).
2 Contents were stirred for 5 minutes.
3 The contents were sterilized with syringe by passing through 0.22 micron
filter aliquot of 5 ml reactions in 15 ml storage vials.
4 Stored at –200 C until use.
Streptomycin sulfate
1. 10 g (one vial) of streptomycin sulfate was weighed and dissolved in 10ml of
sterile PBS.
Amphotericin-B
250 mg of Amphotericin-B was weighed and dissolved in 10 ml of sterile
PBS.
Preparation of Dulbecco’s PBS
1. 9.6 g (one vial) of D-PBS was suspended in 800 ml triple distilled water and
mixed until dissolved.
Materials and Methods
43
2. It was then autoclaved at 1210 C (15 lbl) for 15 minutes.
3. After cooling to room temperature aseptically, sterile 100ml CaCl2 (1mg/ml)
solution and 100 ml MgCl2 (1mg/ml) solution were added and mixed.
Preparation of Lysis buffer
15 g of sodium chloride was weighed and dissolved in 1:1 mixture of
dimethylformamide and distilled water. The final pH was adjusted to 3 with ortho-
phosphoric acid.
Preparation of RPMI-1640 Medium
1 10.39 g (one vial) of RPMI-1640 was weighed in a sterile conical flask.
2 The contents were dissolved in 900 ml of Milli-Q (triple distilled) water by
stirring and the antibiotic solutions were added (100 U/ml Penicillin-G
Sodium, 50 g/ml of streptomycin and 2 g/ml of Amphotericin-B)
3 Once all constituents of the medium were completely added, the pH was
adjusted to 7.2 to 7.5 with 0.1 N HCl.
4 The volume was made up to one liter with triple distilled water.
5 Contents were transferred to the Millipore filtration kettle (Duran,
Germany) supported by 0.22 microns membrane filter, kept in laminar flow
hood that was connected to the outlet by negative pressure pump and
filtered.
6 Pressure was adjusted so that the flow rate of medium from the filtration
unit is 10-12 min/L i.e., 100 ml/min.
Materials and Methods
44
7 5 ml of the sample is taken in T25 tissue culture flask; kept for 24 hours in
CO2 incubator for sterility check.
8 100 ml of sterile Fetal Bovine Serum was added to 900 ml medium.
9 Reconstituted medium was checked for sterility by transferring 5ml of
medium into a T25 tissue culture flask and incubated for 24 hours in CO2
incubator.
Trypsinization
1 The media was aspirated from each flask, being sure to change pipettes
between cell lines to prevent cross contamination.
2 Monolayer was rinsed with 5-10 ml PBS to remove traces of serum and the
rinsing solution was aspirated.
3 1 ml of 0.25 % trypsin-EDTA (Himedia) was added to each flask and
spread evenly over cell monolayer and depending on cell type, the flask was
either placed in hood or in incubator for 2-5 minutes.
4 The flask was gently ‘tapped’ for dislodging the cells.
5 Then the cells were resuspended in 8 ml of the medium containing serum to
stop the action of the trypsin. Gentle pippetting was carried out up and
down for breaking up the clumps.
6 Cell suspension was transferred to a properly labelled 15 ml centrifuge tube.
7 The tubes were centrifuged at 1000 rpm for 5 minutes.
8 The pellet was resuspended in 5-10 ml of medium depending upon the size
of the pellet or cell number.
Materials and Methods
45
MTT assay [122]
Principle
MTT[(3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazoliumbromide] measures
the metabolic activity of the viable cells. The assay is non-radioactive and can be
performed entirely in a microtiterplate (MTP). It is suitable for measuring cell
proliferation, cell viability or cytotoxicity. The reaction between MTT and
‘mitochondrial dehydrogenase’ produces water-insoluble formazan salt. This
method involves culturing the cells in a 96-well microtiterplate, and then incubating
them with MTT solution for approximately 2 hours. During incubation period,
viable cells convert MTT to a water-insoluble formazan dye. The formazan dye in
the MTP is solubilized and quantified with an ELISA plate reader. The absorbance
directly correlates with the cell number. This is applicable for adherent cells cultured
in MTP.
Materials
RPMI-1640, (Himedia, Mumbai India)
TRYPSIN-0.25% ( Gibcos USA)
FBS(Fetal bovine serum) ( Gibcos USA)
MTT 4mg/ml (Himedia)
DMSO (Emerck India)
Lysis buffer (15%SLSin 1:1DMFand water)
Composition of RPMI; 9.54 g/lit, 10%FBS, 2000mg sodium bicarbonate, 250 l each
of penicillin (60mg/ml), streptomycin (100mg/ml), Amphotericin (200mg/ml)
Cell lines used: HepG2 - Human Liver Cancer cells
Materials and Methods
46
Method
0.1ml of the cell suspension (containing 1x105cells) and 0.1ml of the MPP
& MPC (31.25-500 g/ml) in DMSO such that the final concentration of DMSO in
media is less than 1%) were added to the 96 well plates and kept in carbondioxide
incubator with 5% CO2, at 370 C for 72 hours. Blank contains only cell suspension
and control wells contain 1% DMSO and cell suspension
After 72 hours, 20 l of MTT was added and kept in corbondioxide incubator
for 2 hours followed by 80 l of lysis buffer (15%SLSin 1:1 DMF and water). The
plate was covered with aluminum foil to protect it from light. Then the 96 well
plates are kept in rotary shaker for 8 hours
After 8 hours, the 96 well plates were processed on ELISA reader for
absorption at 562nm. The readings were averaged and viability of the test samples
were MPP & MPC with DMSO control (Table 7)
The percentage growth inhibition was calculated using the following formula
Mean OD of Individual Test Group% Growth Inhibition = 100 - ------------------------------------------- X 100
Mean OD of Control Group
5.3.3. Apoptosis
Apoptosis, or programmed cell death, is a highly conserved, tightly
controlled cell suicide process that is regulated by many different intracellular and
extracellular events to ablate neoplastic cells in normal physiological functions.
Apoptosis is controlled by two potential pathways, the mitochondrial pathway and
the death receptor pathway. The mitochondrial pathway is characterized by the loss
of mitochondrial transmembrane potential and release of cytochrome c [123]. The
death receptor pathway is mediated by serial activation of Fas [a cell surface death
Materials and Methods
47
receptor of the tumor necrosis factor (TNF) family of cytokines]. Apoptosis as an
intrinsic suicide serves to remove excess, damaged or infected cells in metazoans.
It's known that apoptosis is characterized by a variety of morphological and
biochemical events, including phosphatidylserine (PS) externalization, chromatin
condensation, genomic DNA fragmentation, and plasma-membrane blebbing
[124,125].
It occurs under physiological conditions (eg, tissue and organ development,
tissue maintenance),anddysregulated apoptosis has been associated with
autoimmune disease and cancer (126,127). Toxic stimuli capable of inducing
apoptosis in susceptible cells include irradiation, DNA-damaging drugs, and
activation of the Fas antigen (126-128). The importance of understanding apoptosis
is underscored further by the fact that the “therapeutic index” of different
antineoplastic therapies may correlate with the differential capacity of tumor and
normal cells to undergo apoptosis (129). “Necrosis” is a form of cell death that
differs from apoptosis (130). Such death usually results from overwhelming damage
to cells, leading to their death without the involvement of a genetically encoded
suicide program (131).
Hoechst staining and photomicroscopy
To analyse the morphological apoptotic changes, 1 X 105 cells seeded in 96-
well plates (370C, 5%CO2), when logarithmic growth phase of cells was reached,
the extractsMPP&MPCwith final concentration of 500 µg/ml or 0.1% DMSO
(negative control) was added, respectively. After 48 h the cells were washed in
phosphate-buffered saline (PBS) and stained for 10 min at room temperature in PBS
containing 40% paraformaldehyde and 10 mg/ml Hoechst 33258. Human Liver
Cancer cells (HepG2) cells for Hoechst staining were grown on sterilized cover slips
and processed as described (132), with modifications. Briefly, after washing one
Materials and Methods
48
time with PBS, cells were fixed with 3.7% formaldehyde in PBS for 10 min, washed
one time with PBS, stained with 0.4 mg/ml Hoechst (Molecular Probes, Eugene,
OR) in PBS for 15 min, washed two times with PBS, and then one time with water.
Cover slips were then air-dried and mounted with Slow Fade (Molecular Probes)
mounting media. Morphological evaluations of nuclear condensation and
fragmentation were performed immediately after staining by means of fluorescent
microscope (Olympus, Japan) at 550 nm of emission.
5.4. DNA BINDING ASSAY
Deoxyribonucleic acid plays an important role in the life process because it
carries heritage information and instructs the biological synthesis of proteins and
enzymes through the process of replication and transcription of genetic information
in living cells. Studies on the binding mechanism of some small molecules with
DNA have been identified as one of the key topics during the past few decades
[133,134]. Moreover it is of great help to understand the structural properties of
DNA, the mutation of genes, the origin of some diseases, the action mechanism of
some antitumour and antivirus drugs and, therefore, to design new and more
efficient DNA targeted drugs to deal with genetic diseases. Anticancer drugs interact
with DNA in many different ways. These include intercalation, non-covalent groove
binding, covalent binding/cross-linking, DNA cleaving and nucleoside-analog
incorporation [135]. As a result of complex formation occurring between DNA and
drug, the thermo dynamic stability and the functional properties of DNA change
[136]. Understanding how complexation affects both the structural and mechanical
properties of DNA is an important step towards elucidating the functional
mechanism of binding agents and may also.
Numerous biological experiments have demonstrated that DNA is the
primary intracellular target of anticancer drugs due to the interaction between small
Materials and Methods
49
molecules and DNA, which cause DNA damage in cancer cells, blocking the
division of cancer cells and resulting in cell death.[137-139] Of these studies, the
interaction of plant extract with DNA has gained much attention. This is due to their
possible application as new therapeutic agents and their phytochemical properties
which make them potential probes of DNA structure and conformation.[140,141]
In order to develop new antitumor drugs which specifically target DNA, it is
necessary to understand the different binding modes a complex is capable of
undertaking. Basically, plant extract interact with the double helix DNA in either a
non-covalent or a covalent way. The former way includes three binding modes:
intercalation, groove binding and external static electronic effects. Among these
interactions, intercalation is one of the most important DNA binding modes as it
invariably leads to cellular degradation. It was reported that the intercalating ability
increases with the planarity of ligands.[142,143].Additionally, the coordination
geometry and ligand donor atom type also play key roles in determining the binding
extent of complexes to DNA [144].
An understanding of the modes of binding of MPP and MPC extracts to
DNA is required to illustrate the principles governing the DNA recognition by such
functional molecules, that is, the factors that decide the affinity and specificity of the
complexes for DNA base sequence. Cationic complexes have been found to both
intercalate into DNA and bind non-covalently in a surface-bound groove-bound
fashion [145]. To assess the mode of DNA binding have been employing several
spectroscopic, electrochemical and other techniques.
Spectrophotometric methods
A compound, when being united to the DNA, modifies its phantom of
absorption, since it undergoes modifications in his electronic structure. In the
absorption phantom displacements in the maximums with respect to binding take
Materials and Methods
50
place free. This one can be by displacement to greater bathochromic effect,
wavelengths, along with a diminution of the molar extinction coefficient. These
spectral change sallow knowing aspects like the binding constant of the complex
[146]. In case of substances, which are non-absorbing, this technique cannot be
employed.
Electrochemical approach
One of the practical applications of electrochemistry is the determination of
electrode redox processes. Due to the existing resemblance between electrochemical
and biological reactions it can be assumed that the oxidation mechanisms taking
place at the electrode and in the body share similar principles[147,148].
Electrochemical investigations of nucleic acid binding molecules–DNA interactions
can provide a useful complement to the spectroscopic methods, e.g.
spectroscopically inactive species, and yield information about the mechanism of
intercalation and the conformation of anticancer drug–DNA adduct [149]. In recent
years, there has been a growing interest in the electrochemical investigation of
interaction between anticancer drugs and DNA. The recent developments of DNA
biosensors have attracted substantial research efforts directed toward clinical
diagnostics as well as forensic and biomedical applications. Electrochemical DNA
biosensors enable us to evaluate and predict anticancer drugs–DNA interaction.
Biosensors are small devices, which utilize biological reactions for detecting
target analytes [150]. A typical biosensor construct has three features a recognition
element, a signal transducing structure and an amplification/processing element.
Various transduction mechanisms such as electrochemical, optical, thermal and
piezoelectric have been employed [151].
There are two types of biosensors depending on the nature of recognition
element. Bio affinity devices rely on the selective binding of the target analyte to a
Materials and Methods
51
surface confined ligand partner (e.g. antibody and oligonucleotide). In contrast, in
bio catalytic devices, an immobilized enzyme is used for recognizing the target
substrate. For example, sensor strips with immobilized glucose oxidase have been
widely used for personal monitoring of diabetes [152].Electrochemical DNA
biosensors comprise a nucleic acid recognition layer, which is immobilized over an
electrochemical transducer. The role of the nucleic acid recognition layer is to detect
the changes occurred in the DNA structure during interaction with DNA-binding
molecules or to selectively detect a specific sequence of DNA. The signal transducer
must determine the change that has occurred at the recognition layer due to the
binding molecules or due to the hybridization; converting this into an electronic
signal which then be relayed to the end user [153].Observing the electrochemical
signal related to DNA–DNA interactions or DNA–drug interactions can provide
evidence for the interaction mechanism, the nature of the complex formed, binding
constant, binding site size and the role of free radicals generated during interaction
in the drug action.
These investigations form a theoretic guide for the design of new anticancer
drugs and chemical treatments of tumor and virus. They are also very valuable for
probing the mechanism of the interaction between anticancer drugs and DNA and
establishing convenient methods to effectively choose specific anticancer drug.
Experimental methodology
Chemicals
All reagents and chemicals were procured from Merck, Mumbai, India. Solvents
used for electrochemical and spectroscopic studies were purified by standard
procedures [154]. DNA was purchased from Bangalore Genei (India). Agarose
(molecular biology grade), ethidium bromide (EB) were obtained from
Materials and Methods
52
Sigma,St.Louis (USA). Tris (hydroxymethyl)amino methane-HCl (Tris–HCl) buffer
solution was prepared using deionized, sonicated triply distilled water.
Experiments
All the experiments involving the interaction of MPP and MPC with Calf
thymus (CT) DNA were carried out in Tris–HCl buffer (50 mMTris–HCl, pH 7.2)
containing 5% ethanol at room temperature. A stock solution of CT DNA was
prepared by dissolving the CT DNA in the Tris-HCl buffer. Solutions of CT DNA
in the above buffer gave a ratio of UV absorbance at 260 and 280 nm, A260/A280 of
1.87, indicating that the CT DNA was sufficiently free from protein [155]. The CT
DNA concentration per nucleotide was determined by absorption spectroscopy at
260 nm using the molar absorption coefficient 260 (6600 M-1 cm-1) [156].
DNA binding experiments
5.4.1. Absorption spectroscopic studies
Electronic absorption spectra were measured on a Shimadzu UV-1601
spectrophotometer in 5 mMTris-HCl buffer (pH 7.1) containing 50 mMNaCl at
room temperature. MPP & MPC were dissolved in absolute ethanol at a
concentration of 5 × 10-3 M. Working solutions were prepared by dilution of the PP
in the absolute ethanol in 5mM Tris-HCl buffer to concentration of 50 M.
Absorption titration experiments were performed by maintaining the extract
concentration as constant at 50 µM while varying the concentration of the CT DNA
within 0 to 400 µM. While measuring the absorption spectra, equal quantity of CT
DNA was added to both the extract solution and the reference solution to eliminate
the absorbance of CT DNA itself. From the absorption data, the intrinsic binding
constant Kb was determined from the following equation (1):
[DNA]/( a f) = [DNA]/( b f) + [Kb b f)]–1 ------------------ (1)
Materials and Methods
53
where a, f, b correspond to Aobsd/[extract], the extinction coefficient for the
free extract, and the extinction coefficient for the extract in the fully bound
form,respectively. A plot of [DNA]/( a f) versus [DNA], where [DNA] is the
concentration of CT DNA in base pairs, gives Kb as the ratio of slope to intercept.
5.4.2 Viscosity measurements
Viscosity experiments were carried on an Ostwald viscometer, immersed in a
thermostated water-bath maintained at a constant temperature at 30.0 ± 0.1°C. DNA
samples of approximately 0.5 mM were prepared by sonicating in order minimize
complexities arising from DNA flexibility [157]. Flow time was measured with a
digital stopwatch three times for each sample and an average flow time was
calculated. Data were presented as ( 0)1/3 versus the concentration of the MPP &
MPC, where is the viscosity of DNA solution in the presence of complex, and 0 is
the viscosity of DNA solution in the absence of complex. Viscosity values were
calculated after correcting the flow time of buffer alone (t0), = (t – t0)/ t0 [158].
5.4.3 Electrochemical methods
Cyclic voltammetric study was performed on a CHI 620C electrochemical
analyzer with three electrode system of glassy carbon (GC) as the working electrode,
a platinum wire as auxiliary electrode and Ag/AgCl as the reference electrode. All
the voltammetric experiments were carried out in single-compartment cells of
volume 5-15 mL. Solutions were deoxygenated by purging with N2 prior to
measurements. Increasing amounts of CT DNA were added directly in to the cell
containing the MPP &MPCsolution (5 X 10-3 M, 5 mMTris-HCl/50 mMNaCl
buffer, pH 7.1). The concentration ranged from 0 to 400 M for CT DNA. The
solution in the cuvette was thoroughly mixed before each scan. All the experiments
were carried out at room temperature.
Materials and Methods
54
5.5 ACUTE AND SUB ACUTE TOXICITY STUDY
Principles and Methods
Life of modern man has been greatly improved by the development of
chemicals in various ways. Like good additives, curing diseases, house ware etc.,
has been said “Without chemicals life wouldn’t be same. At the same times we must
be cautions of over expanded use of chemicals, about which we know so little.
Following decades of reckless and unconscious handling of chemicals which
have resulted in several disasters incidence of pollution. Man has recognized the
need for better control of the present use and the future development of chemical
which should chemically tested and retested before reaching the consumer before
making a judgment, the toxicologist needs the knowledge of the chemical primary
and cumulative toxicity and its mutagenic, teratogenic and carcinogenic potential
which can be obtained from animal studies.
There are four factors contributed to the argument for change. The first is
logistical. New toxicology’s approaches must be established to provide minimum
acceptable databases for these materials. Second existing toxicity testing
methodology using whole animal is expensive and time consuming and cheaper can
significantly reduce economic border. Third, the development of a creative testing
methods which encompass the three R’s (Refinement, reduction, and replacement)
and there incorporation into accepted testing practices. Finally dramatic advances in
biotechnology both on the area of cell, tissue, and organ culture as well as bio-
analytical technique.
Toxicity is defined as any harmful effect of a chemical or a drug on a target
organism. Acute and sub chronic toxicities have been defined by various experts.
The organization for economic corporation and development (OECD) panel of
experts [159] defines acute toxicity as “The adverse effect occurring within a short
Materials and Methods
55
time of (oral) administration of a single dose of a substance or multiple doses given
within 24 hrs. And sub chronic toxicity as “ the advance effects occurring as result
of the repeated daily (oral) dosing of a chemical to experimental annual for part (not
exceeding 10 %) of the life span. Although opinions different on the length of
exposure. Exposure in a sub chronic study generally from 1-3 months. The National
Academy of science (NAS) defines sub chronic exposure from a few days to 6
months [160]. When these times are translated terms of human exposure, acute
toxicity represents life threatening crises of accidental catastrophes and over doses,
suicidal attempts chronic toxicity, on the other hand, represents daily ingestion or
additive or agricultural chemical residues food.
Objectives of Toxicity Testing:
The purpose of toxicity testing is to provide adequate database to make
decisions concerning the toxicology properties of chemical and commercial
products. In some situations, the purpose is to decide whether a material will be safe.
Under the conditions of expected use in other situations, the objective is to establish
the safe limits in condition of use. This process is called hazard evaluation and
would contribute to the introduction of new industrial chemicals and household
products.
Toxicological information which is used in the decision – making process
can be derived from various sources:
1. Historical database
2. Structure – Activating relationship
3. In vivo toxicological testing data from whole animal testing
4. In vivo Toxicological testing data from clinical trials, human volunteers
studies and / or epidemiological studies, and
Materials and Methods
56
5. In vitro toxicological testing data.
It is mainly focused mainly on the contribution in vitro toxicity testing can
make in the toxicological decision. With respect to the type of testing, In vitro
toxicity test can be classified in to three categories.
(1) Screening test
(2) Adjunct test, and
(3) Replacement test.
Screening test provides preliminary data, for definitive testing, whether in
vivo or vitro. Adjunct test provide information which directly taking in to
consideration in to wakening or regulatory decisions. Finally sufficient information
to make on the basic of another existing test.
The second scheme to categorise the test based on the level of toxicological
information.
(1) Toxicity potential
(2) Toxicity potency
(3) Hazard
Toxicity potential are designed to give a qualitative evaluation (often yes /
No response).The next higher level of test are those which can directly measure
relative potency of test materials and thus rank materials as to their relative toxicity.
Final test, which tests hazard i.e., the probability of given toxicological response in
an organism as a function of exposure to provide the highest level of toxicological
information.
Materials and Methods
57
The 28 Day Sub acute Oral Toxicity Study:
It gives the valuable information on the cumulative toxicity of a substance,
target organs, physiological changes and metabolism of a compound at low dose for
a prolonged exposure. A wide variety of adverse effect can be detected. The result
from such studies can provide information’s which will aid in selecting dose level.
For chronic, reproductive and carcinogenicity studies.
The long term safety level of a compound can be predicted from acute or
shorter than sub chronic studies [161, 162]. Acutely non-toxic compounds may be
toxic from prolong exposure, even at low dose level, due to cumulation, changes in
enzyme level and disruption of physiological and biochemical homeostasis.
Oral and inhalation sub chronic studies are generally carried out in three
months. In shorter live animals (Rodents) and one year in longer lived animals
(Dogs and Monkeys). Sub chronic plural studies are usually performed in one month
or tests. The common routes of administration employed in sub chronic toxicities
studies are oral, dermal and respiratory.
Oral administration of a test substance can be carried out by gavage in
capsules or in diet or drinking water 3-4 dose levels of the substance should be
employed. At the end of the dosing period and before, daily observations such as
periodic physical examination, monitoring of body weight and food consumption
and analysis of hematology, biochemistry and urinary parameters have been
analysed. When the animals have been sacrificed at the end of the study, organ
weights are recorded and histopathalogic evaluation is performed.
In Life Observation and Measurements:
Detailed observation of each animal should be done at least once and
preferably twice daily by the duration of the study. If the recovery groups are
Materials and Methods
58
included in the study, these animals should be observed for period of time after the
termination of treatment.
Daily, observation should include close scrutiny for changes in fur texture,
skin, eyes, mucous membrane orifices, and clinical sciences of respiratory,
circulatory, and autonomic and central nervous system and behavioral changes.
Special attention should be given to examine any palatable mass for tumor
incidence. All signs should be recorded, and if details are found during the study.
They should be necrotised within a short period of time (16 hr of death) and the
tissue placed in 10 % neutral buffered formalin or another appropriate fixative,.
Haematology:
Haematology analysis should include haematocrit and hemoglobin
concentration, red blood cell count, white blood cell count, morphology of the red
blood cells, a measure of clotting ability such as prothrombin and thromboplastin
time or platelet count. These should be determined prior to treatment, once during
the study and at the terminal sacrifices. However one must be cognizant of the fact
that the retro orbital bleeding can interfere with ophthalmological examination.
Biochemical Measurement:
Biochemical analysis from the blood sample includes electrolyte balance
carbohydrate and protein metabolism and organ functional tests. It is extremely
important in the establishment for target organ toxicity. To collect the blood sample
animals or starved overnight depending upon the type of animals. However 12 to 16
hr fast is adequate for most animals. For animal such as mice with a high
metabolism rate, 3-4 hrs starving may be sufficient.
Good clinical chemistry analysis will include most, if not all sub chronic
study fasting glucose, serum GOT (AST) and GPT (ALT), alkaline phosphatase,
Materials and Methods
59
gamma glutamyltranspeptidase, blood urea nitrogen (BUN) total protein, albumin,
globulin, total bilirubin, blood creatine, cholesterol acid / base balance, lipids,
Cholinesterase (Plasmas, red blood cell, and / or brain and other biochemical
parameter which facilitate the definition of adverse effects.
Pathological Examination
All tissues from the high dose and control animals and any tissues with
lesions in other groups should be further examined microscopically. If it is having
microscopic lesions, the tissues should be examined from animals in lower dose
groups. Because it is generally expensive and time consuming.
Analysis and Interpretation of Data
With early acute to computers most daily data are stored and analysed
automatically all quantitative and qualitative data, including histopathological
finding, should be processed with appropriate statistics.
Food consumption data along with body weight data may include change in
appetite or change in the efficiency of food utilization by the body, Elevated level of
serum plasma enzymes which have a specific tissues origin are of great value it
identifying target organs. For example out of normal range and statistically
significantly increase in serum glutamic pyruvate tranaminase (SGPT) may suggest
hepatotoxicity. The level of serum alkaline phosphatase is elevated in certain
orleologic disease (e.g. estrogenic sarcoma, rickets) or biliary disorder such as
obstructive jaundice and cirrhosis. Elevated acid phosphatase activity has been
related to carcinoma of the prostate.
Any significant deviation may indicate malfunction of these regulatory
mechanisms, which may be related to the chemical exposure. Acid / base balance is
regulated by renal and respiratory systems, and a significant deviation may indicate
Materials and Methods
60
respiratory or renal problems. Renal damage may be substantiated by an increase in
BUN level, the appearance of stones, calculi protein or epithelial cells in the wire.
Any changes in the morphology of blood cells may indicate blood dyscrasia.
EXPERIMENTAL METHODS OF TOXICITY TESTING
5.5.1. Acute Oral Toxicity Studies
Animals
Adult female Wistar rats (125-150 g) were used for acute toxicity. These
animals were kept in polypropylene cages under identical animal house condition
and provided with standard pellet and water ad libitum. Each cage contained 3 rats
of the same sex with a bedding of husk, and 12-hour light/dark cycles were
provided. Environmental conditions were maintained at a temperature of 22°C ± 2°C
and a relative humidity of 60% ± 10%.
Toxicity studies conducted as per internationally accepted protocol drawn
under OECD No 420 guidelines. Test drugs used weremethanolic extracts of P.
polyphyllus (MPP)andP.cineraria(MPC). The overnight fasted rats were divided
into 6 groups, each group consisting of 3 animals. The MPP& MPCextracts were
given separately in various doses (50, 500, 1000, 2000 mg/kg) by oral route. After
administration of the extracts, the animals were observed continuously for the first
two hours and 24 hrs to detect changes in the behavioural responses and also for
tremors, convulsion, salivation, diarrhoea, lethargy, sleep and coma and monitored
for any mortality.
5.5.2.SUB ACUTE TOXICITY STUDIES
Experimental design
Seven groups of rats were used in sub-acute toxicity study of MPP &
MPCandeach group consists of 6 rats. The groups and treatment were designed as
follows
Materials and Methods
61
Group 1 - Control treated with saline (2 ml/kg, p.o.)
Group 2 - MPP (200 mg/kg, p.o.)
Group 3 - MPP (500 mg/kg, p.o.)
Group 4 - MPP (1000 mg/kg, p.o.)
Group 5 - MPC (200 mg/kg, p.o.)
Group 6 - MPC (500 mg/kg, p.o.)
Group 7 - MPC (1000 mg/kg, p.o.)
Seven groups of rats received MPP& MPC extracts at dose of 200, 500 and
1000 mg/kg (low dose, intermediate dose and high dose) orally for 28 days. The
group which served as control received equivalent quantity of normal saline orally.
Animals were observed for signs and symptoms, behaviour alteration, food and
water intake and body weight changes. All animals were observed twice daily for
mortality during the 28 day period of study. The weight of each rat was recorded on
day 0 and at weekly intervals throughout the course of the study. The group mean
body weights were calculated.
At the end of the 28-day period the animals were fasted overnight. The
following morning, each animal was heparinised and blood samples were collected
from the orbital sinus. The blood sample was collected after 24 h of the last doses of
alcoholic extracts.
Haematological analyses were performed in total blood was collected in
heparinised funnels and tubes with EDTA The relative blood indices like white
blood cell count (WBC), red blood cell count (RBC), haemoglobin (Hb), erythrocyte
sedimentation rate (ESR), platelets, clotting time and packed cellular volume (PCV)
were determined using routine method [163]. In addition, Biochemical analyses
were performed in serum obtained after centrifugation of total blood without
anticoagulants, at 2400 rpm for 15 min. The analysis of blood glucose[164],
Materials and Methods
62
Cholesterol[165], Serum aspartate amino transferase (AST)[166],Alanine amino
transferase(ALT)[167], Alkaline phosphatase, Total bilirubin[168], Urea and
BUN[169], Total Protein & Albumin[170]and creatinine[171] were estimated in
serum. Urine samples were also collected at the end of the study period and
analyzed for specific gravity, pH, glucose, proteins, ketones, and occult blood. At
the end of 28 days, experiment animals were autopsied and vital organs viz. Liver,
kidney, spleen, lung, heart and brain were removed, weighed and subjected to gross
pathological examination. [172,173]
Since liver and kidney are organs of metabolism and excretion, potentially
toxic agents are likely to affect them. So, portions of these organs were fixed in
buffered 10% formalin and 5 m thick paraffin sections were made and stained with
haematoxylin and eosin [174] for microscopic examination. The results on sub
chronic toxicity studies are presented in Tables 11 to 16 and Fig. No 14.
Statistical analysis
The values were expressed as mean ± SEM. Statistical analysis was
performed by one way analysis of variance (ANOVA) followed by Tukey multiple
comparison tests. P values < 0.05 were considered as significant.
5.6 CHEMOPREVENTIVE ACTION AGAINST DEN INDUCED LIVERCARCINOMA
Animals
Healthy Male Wistar albino rats (6-8 weeks old) were used throughout the
study. The animals were purchased from King Institute of Preventive Medicine,
Chennai-600 034 and Animal House Facility, Ratnam Institute of Pharmacy,
Nellore, India, and maintained in a controlled environmental condition of
temperature (23 2 C) and relative humidity (50-70%) on alternatively 12 hr
light/dark cycles. All animals were fed standard pellet diet (Gold Mohor rat feed,
Materials and Methods
63
M/s. Hindustan Lever Ltd., Mumbai) and water ad libitum. This research work on
Wistar albino Male rat was sanctioned and approved by the Institutional animal ethical
committee (IAEC. No. 02/2010).
Sources of Chemicals
N-NitrosoDethylamine [DEN], bovine serum albumin, 2,4,6-Trinitro benzene
sulfonate, reduced glutathione, ribonuclease were obtained from Sigma Chemical
Company, St. Louis, MO, USA.
Ascorbic acid, adenosine triphosphate, 1-amino 2-naphthol 4-sulphonic acid
(ANSA) and glutathione were obtained from Sisco Research Laboratories, Mumbai,
India. 1-choloro-2, 4-dinitrobenzene (CDNB) and 5,5’-dithionitrobenzoic acid
(DTNB) were obtained from S.D. Fine Chemicals, Mumbai, India. All other
chemicals used were of analytical grade obtained from Sisco Research Laboratories
Pvt. Ltd., Mumbai, India and Glaxo Laboratories, CDH division, Mumbai, India.
Experimental design
The rats were divided into 6 groups, each group consisting of six animals.
Liver tumor was induced in group 2, 3, 4, 5 and 6 with single intraperitoneal
injection of DEN at a dose of 200 mg/kg body weight in saline. Two weeks after
DEN administration, the carcinogenic effect was promoted by 0.05% phenobarbitol,
which was supplemented to the experimental animals through drinking water for up
to 20successive weeks [175].
Group I - Control animals treated with distilled water orally for 20 weeks
Group II - N-NitrosoDiethylamine (DEN) (200 mg/kg b. wt, by i.p) treated
at single dose.
Materials and Methods
64
Group III - DEN (as in group II) and MPP (200 mg/kg b.wt, dissolved in
0.3% cmc) simultaneously for 20 weeks from the first dose of
DEN (as in Group II)
Group IV - MPP (400 mg/kg b.wt, dissolved in 0.3% cmc) (as in Group III)
simultaneously for 20 weeks from the first dose of DEN (as in
Group II)
Group V - DEN (as in group II) and MPC (200 mg/kg b.wt, dissolved in
0.3% cmc) simultaneously for 20 weeks from the first dose of
DEN (as in Group II)
Group VI - MPC (400 mg/kg b.wt, dissolved in 0.3% cmc) (as in Group III)
simultaneously for 20 weeks from the first dose of DEN (as in
Group II)
After the experimental period of 20 weeks, the animals were
sacrificed and the parameters of interest were assayed.
Collection of blood and organs
All the experimental animals were killed by cervical decapitation after the
experimental period. The blood was collected for the separation of serum to
determine blood parameters. The liver was removed, weighed, morphological
changes and tumour incidence were observed. A portion of liver tissues were
homogenized with motor driven Teflon coated homogeniser in ice-cold 0.1M Tris-
HCl buffer pH 7.4 to obtain 10% homogenate.
Assay of liver marker enzymes
Alkaline phosphatase (Ortho phosphoric acid – monoester phospho hydrolase)
Alkaline phosphatase was assayed by the method of Kind (1971).[176]
Materials and Methods
65
Reagents
1. Carbonate-bicarbonate buffer: 0.1 M pH 10.0
2. Disodium phenyl phosphate: 0.1 M
3. MgCl2: 0.1M
4. Sodium Carbonate: 15%
5. Folin’s phenol reagent
6. Standard: 100 mg of phenol was dissolved in 100 ml of distilled water.
Procedure
The incubation mixture containing 1.5 ml of buffer, 1 ml of substrate and 0.1
ml of MgCl2 were preincubated at 37oC for 10 minutes. Then 0.1 ml of homogenate
was added and incubated at 37oC for 15 minutes. The reaction was arrested by the
addition of 1.0 ml of folin’s phenol reagent. Control without enzyme was also
incubated and the homogenate was added after the addition of folin’s phenol
reagent. Then 1.0 ml of sodium carbonate was added. After 10 minutes the blue
colour developed was read at 640nm using a photochem colorimeter. The enzyme
activity was expressed as µmoles of phenol liberated /min/mg protein under
incubation conditions.
Aspartate amino transferase (L-Aspartate: 2-oxoglutarate amino transferase)
Aspartate amino transferase was estimated by the method of King
(1965).[177]
Reagents
1. Phosphate buffer: 0.1M pH 7.5.
2. Substrate: 1.33gm of aspartic acid and 15 mg of 2- oxoglutarate were
dissolved in 20.5 ml of 1N NaOH and made up to 100ml with buffer.
Materials and Methods
66
3. 2,4-Dinitropheneyl hydrazine (DNPH): 0.02% 0f DNPH in 1N HCl
4. NaOH: 0.4N
5. Standard: 11mg of sodium pyruvate was dissolved in 100 ml of phosphate
buffer. This contains 1M of pyruvate/ml.
Procedure
One ml of substrate was incubated at 37oC for 10 minutes. Then 0.2ml of
enzyme was added and the mixture was incubated at 37oC for 1 hour. To the control
tubes, the enzyme was added after the reaction and it was arrested by the addition of
1.0 ml of DNPH reagent. The tubes were kept at room temperature for 30 minutes.
Then 5ml of NaOH was added. A set of pyruvate solution standard were also treated
in a similar manner. The colour developed was read at 540nm using a photochem
colorimeter.
The enzyme activity was expressed as µmoles of pyruvate liberated /min/mg
protein under incubation conditions.
Alanine amino transferase (L – Alanine: 2- oxoglutarate amino transferase)
Alanine amino transferase was assayed by the method of King (1965).[177]
Reagents
1. Phosphate buffer: 0.1M pH 7.5.
2. Substrate: 1.78 gm of DL- alanine and 30 mg of 2- oxoglutarate were
dissolved in 20ml of buffer 0.5ml of 1N sodium hydroxide was added and
made up to 100ml with distilled water.
3. DNPH: 0.02% 0f DNPH in 1N HCl
Materials and Methods
67
4. NaOH: 0.4N
5. Standard: 11mg of sodium pyruvate was dissolved in 100 ml of phosphate
buffer. This contains 1M of pyruvate/ml.
Procedure
1.0 ml of substrate was incubated at 37oC for 10 minutes. Then 0.2ml of
enzyme solution was added. The tubes were incubated at 37oC for 30 minutes. To
the control tubes, enzyme was added after arresting the reaction with 1.0ml of
DNPH reagent. The tubes were kept at room temperature for 20 minutes. Then
5.0ml of 4N NaOH was added and the colour developed was read at 540nm using a
photochemcolorimeter.The enzyme activity was expressed as µmoles of pyruvate
liberated /min/mg protein under incubation conditions.
Assay of -Glutamyltranspeptidase
The activity of -glutamyltranspeptidase was estimated according to the method
of Orlowski and Meister (1965). [178]
Reagents
1. 0.1 M Tris-HCl buffer, pH 8.5
2. Substrate (30.37 mg of L- -glutamyl-p-nitroanilide was dissolved in 10 ml of
water by heating at 50-60 C)
3. Glycyl glycine (13.2 mg/10 ml)
4. p-Nitroaniline
Materials and Methods
68
Procedure
The incubation mixture contained 0.5 ml of substrate, 1 ml of Tris-HCl buffer
2.2 ml of glycyl glycine, 0.2 ml of homogenate and the total volume was made up to 4
ml with water. After incubation for 30 min at 37 C, the samples were heated at 100 C
for 5 min and centrifuged. The amount of p-nitroaniline in the supernatant was
measured at 410 nm.
The activity of -glutamyltransferase was expressed as mole of p-nitroaniline
formed/min/mg protein.
Estimation of Protein
Protein was estimated by the method of Lowry et al. (1951).[179]
Reagents
1. Alkaline copper reagent
Solution A: 2% sodium carbonate in 0.1 N NaOH
Solution B: 0.5% copper sulphate in 1% sodium potassium tartarate 50 ml of
solution A was mixed with 1 ml of solution B just before use.
2. Folin's phenol reagent (commercial reagent, 1:2 dilution)
3. Bovine serum albumin (BSA).
Procedure
To 0.1 ml of suitably diluted plasma/homogenate/hemolysate, 0.9 ml of water
and 4.5 ml of alkaline copper reagent were added and kept at room temperature for10
min. Then 0.5 ml of Folin’s reagent was added and the colour developed was read after
20 min at 640 nm. The level of protein was expressed as mg/g tissue or mg/dl plasma.
Materials and Methods
69
ENZYMIC AND NONENZYMIC ANTIOXIDANTS
Assay of superoxide dismutase (SOD)
The activity of superoxide dismutase was determined by the method of
Marklund and Marklund (1974).[180]
Reagents
1. 0.4 mMpyrogallol in air-saturated 0.1 M Tris-cacodylic acid buffer, pH 8.2
containing 2 mMdiethylenetriaminepenta acetic acid (DETPA).
Procedure
The assay mixture contained 1 ml of pyrogallol-Tris-DETPA, 0.2 ml of
homogenate and 0.8 ml of water. The rate of pyrogallol autoxidation is taken from
the increase in absorbance at 420 nm. The activity of SOD was expressed as
units/min/mg protein. One unit of the enzyme is defined as the amount of enzyme,
which inhibits the rate of pyrogallol autoxidation by 50%.
Assay of catalase
The activity of catalase was assayed by the method of Sinha (1972).[181]
Reagents
1. Dichromate/acetic acid reagent (5% solution of potassium dichromate in
acetic acid (1:3))
2. 0.01 M Phosphate buffer, pH 7.0
3. 0.2 M Hydrogen peroxide (H2O2)
Materials and Methods
70
Procedure
The assay mixture contained 4 ml of H2O2, 5 ml of phosphate buffer and 1 ml
of homogenate. One ml portions of the reaction mixture was withdrawn and blown into
2 ml of dichromate/acetic acid reagent at 1 min intervals. Then the mixture was heated
for 10 min in a boiling water bath. After cooling, the OD was measured at 570 nm.
The activity of catalase was expressed as moles of H2O2 consumed/min/mg
protein.
Assay of glutathione peroxidase (GPx)
The activity of GPx was assayed by the method of Rotrucket al. (1973).[182]
Reagents
1. 0.32 M Phosphate buffer, pH 7.0
2. 0.8 mM EDTA
3. 10 mM Sodium azide
4. 3 mM reduced glutathione
5. 2.5 mM H2O2
6. 10% TCA
7. 0.3 M Disodium hydrogen phosphate
8. DTNB solution (40 mg of DTNB in 100 ml of 1% sodium citrate)
9. Reduced glutathione
Procedure
The reaction mixture consisted of 0.2 ml each of EDTA, sodium azide, H2O2,
0.4 ml of phosphate buffer, 0.1 ml homogenate and was incubated at 37 C at different
time intervals. The reaction was arrested by the addition of 0.5 ml of TCA and the
Materials and Methods
71
tubes were centrifuged at 2000 rpm. To 0.5 ml of supernatant, 4 ml of disodium
hydrogen phosphate and 0.5 ml DTNB were added and the colour developed was read
at 420 nm immediately.
The activity of GPx was expressed as moles of glutathione oxidized/min/mg
protein.
Assay of glutathione reductase (GR)
The activity of GR was measured by the method of Staalet al. (1969).[183]
Reagents
1. 0.3 M Phosphate buffer, pH 6.8
2. 0.25 M EDTA
3. 12.5 mM oxidized glutathione
4. 3 mM NADPH
Procedure
The reaction mixture containing 1 ml of phosphate buffer, 0.5 ml of EDTA, 0.5
ml of oxidized glutathione and 0.2 ml of NADPH was made up to 3 ml with water.
After the addition of 0.1 ml of homogenate the change in optical density at 340 nm was
monitored for 2 min at 30 sec intervals. The activity of GR was expressed as nmoles of
NADPH oxidized/min/mg protein.
Estimation of reduced glutathione (GSH)
The level of reduced glutathione was measured by the method of Moron et al.
(1979).[184]
Materials and Methods
72
Reagents
1. 10% TCA
2. 0.6 mM 5, 5 -dithiobis-2-nitrobenzoic acid (DTNB) in 0.2 M sodium phosphate
3. 0.2 M Phosphate buffer, pH 8.0
Procedure
One ml of homogenate was precipitated with 1 ml of TCA and the precipitate
was removed by centrifugation. To 0.5 ml of supernatant, 2 ml of DTNB was added
and the total volume was made up to 3 ml with phosphate buffer. The absorbance was
read at 412 nm. The level of glutathione was expressed as g/mg protein.
Estimation of ascorbic acid
The level of ascorbic acid was estimated by the method of Omayeet al.
(1979).[185]
Reagents
1. 5% TCA
2. DTC reagent (3 g of 2,4-dinitrophenyl hydrazine, 0.4 g of thiourea and 0.05
g of copper sulphate were dissolved in 100 ml of 9 N sulphuric acid)
3. 65% sulphuric acid
4. Ascorbic acid
Procedure
To 0.5 ml of homogenate, 0.5 ml of water and 1 ml of TCA were added, mixed
thoroughly and centrifuged. To 1 ml of the supernatant, 0.2 ml of DTC reagent was
added and incubated at 37 C for 3 hrs. Then 1.5 ml of sulphuric acid was added, mixed
Materials and Methods
73
well and the solutions were allowed to stand at room temperature for another 30 min.
The colour developed was read at 520 nm. The level of ascorbic acid was expressed
as g/mg protein.
Estimation of vitamin E
The level of vitamin E was estimated by the method of Desai (1984).[186]
Reagents
1. Ethanol
2. Petroleum ether
3. 0.2% 4,6-diphenyl-1,10-phenanthroline in ethanol
4. 0.001 M Ferric chloride in ethanol
5. 0.001 M Ortho-phosphoric acid in ethanol
6. -Tocopherol acetate
Procedure
To 1 ml of homogenate, 1 ml of ethanol was added and thoroughly mixed.
Then 3 ml of petroleum ether was added, shaken rapidly and centrifuged. 2 ml of
supernatant was taken and evaporated to dryness. To this 0.2 ml of
bathophenanthroline was added. The assay mixture was protected from light and 0.2 ml
of ferric chloride was added followed by 0.2 ml of Ortho-phosphoric acid. The total
volume was made up to 3 ml with ethanol. The colour developed was read at 530
nm.The level of vitamin E was expressed as g/mg protein.
5 -Nucleotidase
5 -Nucleotidase was assayed by the method of Lulyet al. (1972).[187]
Materials and Methods
74
Reagents
1. Tris-HCl buffer 184 mM, pH 7.5: 2.23 g Tris was dissolved in 100 ml of
demonized water and pH was adjusted to 7.5 with HCl.
2. Magnesium sulphate 50 mM: 616.2 mg of MgSO4 was dissolved in 50 ml of
demonized water.
3. Potassium chloride 650 mM: 1.211 g of KCl was dissolved in 25 ml of
demonized water.
4. EDTA 1 mM: 37.23 mg of EDTA was dissolved in 100 ml of demonized
water.
5. TCA 10%.
6. Substrate 40 mM: 5 -Adenosine monophosphate was prepared by dissolving
69.4 mg in 5.0 ml of demonized water.
Procedure
The reaction mixture contained 1.0 ml of Tris-HCl buffer and 0.1 ml each of
magnesium sulphate, potassium chloride, EDTA, substrate and water. The reaction was
initiated by the addition of 0.2 ml plasma or tissue homogenate and incubated at 37 C
for 15 minutes. The reaction was arrested by the addition of 2.0 ml of 10% TCA and
centrifuged. The phosphorus liberated in the supernatant was estimated by the method
of Fiske and Subbaroa (1925). The enzyme activity was expressed as nmoles of
inorganic phosphorus liberated/min/mg protein.
Assay of lactate dehydrogenase
The activity of lactate dehydrogenase was assayed by the method of King
(1965). [188]
Materials and Methods
75
Reagents
1. 0.1 M Glycine buffer, pH 7.4
2. Buffered substrate (4 g of lithium lactate was dissolved in 75 ml of 0.1N
NaOH and was made up to 200 ml with glycine buffer)
3. NAD+ (5 mg/ml)
4. 0.02% DNPH in 1 N HCl
5. 0.4 N NaOH
6. Pyruvate
Procedure
To 1 ml of buffered substrate, 0.1 ml of serum, 0.2 ml of water and
0.2 ml of NAD+ were added and incubated at 37 C for 15 min. Then 1 ml of DNPH
was added and again incubated for another 15 min at 37 C. Then 0.5 ml of NaOH was
added and the colour developed was read at 420 nm. The activity of lactate
dehydrogenase was expressed as mole of pyruvate liberated/min/mg protein.
AssayofAryl hydrocarbonhydroxylase(AHH)
The AHHassaywas modifiedfromthe methodofMildredetal. (1981).[189]
Reagents
1. 62.5mMTris-HClbuffer
2. 3.75mMMgCl2
3. Bovineserumalbumin
4. 10 mMNADPH
5. 2mMBenzo(a)pyreneinmethanol
6. 1NNaOH
Materials and Methods
76
Procedure
TheassayusingB(a) pwasperformedinareactionmixturecontaininga total
volume of 1ml which included Tris-HCl buffer, MgCl2: bovineserum albumin
(1:25mg/ml); 0.1 ml supernatant suspension and 50µl of NADPH in Tris-HCl buffer,
with 50 ml of B(a) pinmethanol (0.54mg/ml) added to initiate the reaction. The
reaction was incubated for 10 min in a covered, shaking water bathat 37°C and wast
erminated by adding 1.0 ml acetone and 3.25 ml hexane. The mixture was shakenvig
orously in the dark to extract the B(a) panditsmetabolites. 1 ml sample of the organic
phase was extracted with 3.0 ml of 1N NaOH and the AHH were examined in
spectrophotometer. The enzyme activity was expressed as phenolicmetabolite
formed/min /mgprotein.
Estimation of Adenosine triphosphatase
Na+, K+-ATPase (Adenosine triphosphatase)
Na+, K+-ATPase was estimated by the method of Bonting (1970).[190]
Reagents
1. Tris-HCl buffer 184 mM, pH 7.5.
2. MgSO4, 50 mM
3. KCl, 50 mM
4. NaCl, 600 mM
5. EDTA, 1 mM
6. ATP, 40 mM
7. TCA, 10%
8. Ammonium molybdate, 2.5%
9. ANSA.
Materials and Methods
77
Procedure
The incubation mixture contained 1 ml of Tris-HCl buffer, 0.2 ml each of
magnesium sulphate, potassium chloride, sodium chloride, EDTA, ATP and the
homogenate. The mixture was incubated at 37 C for 15 minutes. The reaction was
arrested by the addition of 1 ml of 10% TCA, mixed well and centrifuged. The
phosphorus content of the supernatant was estimated as described in phosphorus
estimation.The enzyme activity was expressed as moles of inorganic phosphorus
liberated/min/mg protein.
Ca2+ATPase
The activity of Ca2+ATPase was assayed according to the method of Hjerten
and Pan (1983).[191]
Reagents
1. Tris-HCl buffer 125 mM, pH 8.0
2. CaCl2, 50 mM
3. ATP, 10 mM
4. TCA, 10%.
Procedure
The incubation mixture contained 0.1 ml each of Tris-HCl buffer, calcium
chloride, ATP and enzyme preparation. After incubation at 37 C for 15 minutes, the
reaction was arrested by the addition of 1 ml of TCA. The amount of phosphorous
liberated was estimated as described in phosphorus estimation. The enzyme activity
was expressed as moles of inorganic phosphorous liberated/min/mg protein.
Materials and Methods
78
Mg2+ATPase
The activity of Mg2+ ATPase was assayed by the method of Ohinishi
et al. (1962).[192]
Reagents
1. Tris-HCl buffer 375 mM, pH 7.6
2. MgCl2, 25 mM
3. ATP, 10 mM
4. TCA, 10%.
Procedure
The incubation mixture contained 0.1 ml each of Tris-HCl buffer, magnesium
chloride, ATP, and enzyme preparation. The reaction mixture was incubated at 37 C
for 15 minutes. The reaction was arrested by the addition of 1 ml TCA. The liberated
phosphorous was estimated as described in phosphorous estimation. The enzyme
activity was expressed as moles of inorganic phosphorous liberated/min/mg.
Estimation of Glycoproteins
Acid hydrolysis of tissues for estimation of hexose and hexosamine
To the weighed amount of defatted tissues, 2 ml of 4 N HCl was added and the
mixture was refluxed at 100 C for 4 hrs in a test tube with suitable marble lids. The
hydrolysate was then neutralised with NaOH. Aliquots of the neutralised samples were
taken for the analysis.
Estimation of hexose
Hexose level was estimated by the method of Niebes (1972).[193]
Materials and Methods
79
Reagents
1. Orcinol - Sulphuric acid reagent
Solution A : 60 ml of concentrated sulphuric acid was mixed with 40 ml of
distilled water.
Solution B: 1.6 g of orcinol (recrystallized from benzene) was dissolved in
100 ml of distilled water. 7.4 ml of solution A was mixed with 1 ml of solution
B before use.
2. Standard: 5 mg of each of galactose and mannose were dissolved in 100
ml of distilled water (100 g/ml).
Procedure
0.5 ml of the neutralized solution was made up to 1 ml with distilled water and
added 8.5 ml of ice-cold orcinol reagent. The mixture was heated at 80 C for 15
minutes, cooled and left in the dark for 25 minutes for colour development. Then the
absorbance was read at 540 nm in a Photochem colorimeter. Standard solutions
containing 25-100 g of hexose were treated in a similar manner. The hexose content
was expressed as mg/g wet tissue.
Hexosamine
Hexosamine content was estimated by the method of Wagner (1974).[194]
Reagent
1. Acetyl acetone reagent
Solution A: Trisodium phosphate 0.1 M
Solution B: Potassium tetra borate 0.5 N
Materials and Methods
80
2. 5 ml of acetyl acetone was added to mixture of solution A and solution
B in the ratio of 98:2 (v/v)
3. Ehrlich's reagent
320 mg of p-dimethyl aminobenzaldehyde was dissolved in 21 ml of
isopropanol and 3 ml of concentrated HCl
4. Standard: Galactosamine was prepared in the concentration range of
100 g/ml in water.
Procedure
0.5 ml of the neutralized sample was made up to 1 ml with distilled water.
Standard galactosamine (in the range of 10-40 g) was also made up to 1 ml with
distilled water. 0.6 ml of acetyl acetone reagent was added to all the tubes and heated in
a boiling water bath for 30 minutes. After cooling, 2 ml of Ehrlich's reagent was added
and the contents were shaken well. The pink colour developed was measured at 540
nm against the reagent blank. Hexosamine content was expressed as mg/g wet tissue.
Sialic acid
The weighed amounts of defatted tissues were hydrolysed with 1.0 ml of 0.1 N
sulphuric acid at 80 C for 60 minutes to release sialic acid bound to the proteins. The
solution was neutralised with NaOH. Sialic acid level was determined by the method of
Warren (1957).[195]
Reagents
1. Periodic acid, 0.25 M.
2. 4% Sodium metaarsenite
Materials and Methods
81
3. Thiobarbituric acid
4. Acidified butanol
5. Standard sialic acid: 10 mg of N-acetyl neuraminic acid was dissolved in
100 ml of distilled water.
Procedure
0.5 ml of the neutralised sample was taken along with the standards
(in the range of 10-40 g). Blank contained 0.5 ml of 0.1 N sulphuricacid. 0.25 ml of
periodate was added to all tubes at 37 C. After 30 minutes, 0.25 ml of arsenite solution
was added to inhibit the reaction. Contents were mixed well and 2 ml of thiobarbituric
acid was added and the tubes were heated in a boiling water bath for 6 minutes. After
cooling, the pink colour developed was extracted into 5 ml of acidified butanol phase
and was measured at 540 nm against a reagent blank. Thesialic acid content was
expressed as mg/g wet tissue.
ISOLATION OF MITOCHONDRIA AND MICROSOMES
The mitochondria were isolated by the method of Johnson and Lardy (1967)
[196] and microsomes by Omuraet al. (1964). [197]
Reagents
1. 0.05 M Tris-HCl buffer, pH 7.4 containing 0.25 M sucrose
2. 0.05 M Tris-HCl buffer, pH 7.4 containing 0.15 M potassium chloride
A 10% (w/v) homogenate was prepared in 0.05 M Tris-HCl buffer, pH 7.4
containing 0.25 M sucrose and centrifuged at 600 x g for 10 min. The supernatant
fraction was decanted and centrifuged at 15,000 x g for 5 min. The resultant
mitochondrial pellet was then washed and resuspendedin the same buffer. The post
Materials and Methods
82
mitochondrial fraction was further centrifuged at 105,000xgfor 60 min. The
microsomal pellet was suspended in 0.05 M Tris-HCl buffer, pH 7.5 containing 0.15 M
KCl.The purity of mitochondrial and microsomal fractions were assessed by measuring
the activities of succinate dehydrogenase and glucose-6-phosphate dehydrogenase
respectively.
ESTIMATION OF PHASE-I ENZYMES
Estimation of Cytochrome P450
Cytochrome P450 was estimated by the method of James et al (2008).[198]
Reagents
1. 0.1 M Phosphate buffer, pH 7.0
2. Sodium dithionate
3. Carbon monoxide
Procedure
Microsomes suspended in phosphate buffer (4 mg/ml) were reduced by a few
milligrams of solid sodium dithionate. Then 1 ml of water saturated with carbon
monoxide was added. The absorbances of the samples were scanned at 400-500
nm.The level of cytochrome P450 was expressed as nmole/mg protein based on molar
extinction coefficient.
Estimation of Cytochrome b5
The amount of cytochrome b5 was measured by the method of James et al
(2008).[198]
Materials and Methods
83
Reagents
1. 0.1 M Phosphate buffer, pH 7.0
2. 0.4 mM NADH
Procedure
To the microsomal suspension, containing 4 mg of protein/ml in phosphate
buffer, 1 ml of NADH was added. The absorbance spectrum between 400-500 nm was
read against the blank containing microsomal suspension alone. The level of
cytochrome b5 was calculated using the molar extinction coefficient of 185 mM/cm
between 424-409 nm and was expressed as nmoles/mg protein.
Assay of NADPH-cytochrome P450reductase
The activity of NADPH-cytochrome P450reductase was assayed by the method
of James et al (2008).[198]
Reagents
1. 0.3 M Phosphate buffer, pH 7.6
2. 0.045 mM NADPH
3. 1 mM Potassium cyanide
4. 0.05 mM Cytochrome c
Procedure
The assay mixture containing 2.5 ml of buffer, 0.2 ml of potassium cyanide,
0.1 ml of cytochrome c was mixed gently. After 3 min, 0.1 ml of NADPH was added
and the change in optical density was recorded at 30 seconds intervals for 3 min at
550 nm.The activity of NADPH-cytochrome P450reductase was expressed as nmoles of
cytochrome C reduced/min/mg protein.
Materials and Methods
84
PHASE-II ENZYMES
UDP-GlucuronylTransferase
The UDP-Glucuronyltransferase was estimated by the method by Reitman and
Frankel(1957).[199]
Reagents
1. Tris-HCl buffer 1 M, pH 7.4: 12.11 g of Tris was dissolved in 100 ml of
water and pH was adjusted to 7.4 with HCl.
2. Triton X-100 (0.25%)
3. MgCl2 50 mM: 47.5 mg of MgCl2 was dissolved in 10 ml of water.
4. p-Nitrophenol 5 mM: 0.84 mg of p-nitrophenol was dissolved in 1 ml of
water.
5. UDP-Glucuronic acid 30 mM: 19.38 mg of UDP-glucuronic acid was
dissolved in 1 ml of water.
6. TCA 5%.
7. NaOH 2 M.
Procedure
The incubation mixture containing 0.5 ml buffer, 0.2 ml Triton X-100, 0.05 ml
MgCl2, 0.05 ml p-nitrophenol, 0.18 ml water and 0.1 ml enzyme was incubated at 37 C
for 2 minutes. Then 0.1 ml of UDP-glucuronic acid was added. Then 0.1 ml aliquot of
this mixture was arrested at 0, 10 and 15 minutes with TCA and centrifuged. To one ml
of the supernatant, 0.25 ml of NaOH was added and read at 450 nm using a
photochemcolorimeter.The enzyme activity was expressed as nmoles/min/mg protein.
Materials and Methods
85
Glutathione S-transferase (EC 2.5.1.18)
Glutathione S-transferase was assayed by the method of Habiget al.
(1974).[200]
Reagents
1. 0.3 M Phosphate buffer, pH 6.5
2. 30 mM 1 chloro-2, 4-dinitrobenzene (CDNB)
3. 30 mM GSH
Procedure
To 1.0 ml of phosphate buffer, 0.1 ml of CDNB, 1.7 ml of water and 0.1 ml of
enzyme source was added. After 5 minutes of incubation at 37 C, 0.1 ml of GSH was
added and the change in optical density was measured immediately for 3 minutes. A
complete assay mixture without enzyme was used a control. Optical density was
measured at 340 nm in a Shimadzu spectrophotometer.Activity of glutathione S-
transferase was expressed as moles of CDNB of conjugate formed/minute/mg
protein.
Estimation of Macromolecular Damages
Assay of lipid peroxidation (LPO)
The level of lipid peroxides was assayed by the method of Ohkawaet al.
(1979).[201]
Reagents
1. 8.1% Sodium dodecyl sulphate (SDS)
2. 20% Acetic acid, pH 3.5 adjusted with NaOH
Materials and Methods
86
3. 0.8% Thiobarbituric acid (TBA)
4. n-Butanol/pyridine mixture (15:1 v/v)
5. 1, 1, 3, 3-tetraethoxypropane
Procedure
To 0.2 ml of homogenate, 0.2 ml of SDS, 1.5 ml of acetic acid and 1.5 ml of
TBA were added. The mixture was made up to 4 ml with water and then heated in an
oil bath at 95 C for 60 min using glass ball as a condenser. After cooling, 1 ml of water
and 5 ml of n-butanol/pyridine mixture were added and shaken vigorously. After
centrifugation at 4000 rpm for 10 min, the absorbance of organic layer was measured at
532 nm. The level of lipid peroxides was expressed as nmoles of MDA formed/mg
protein.
Extraction of nucleic acids
The nucleic acids were extracted by the method of Schneider (1957).[202]
Known amount of tissues were homogenised in 5.0 ml of ice-cold distilled water using
Potter-Elvehjemhomogeniser with a Teflon pestle. 5.0 ml of 5% TCA was added to the
homogenate and this was kept in ice for 30 minutes to allow complete precipitation of
proteins and nucleic acids. The mixture was centrifuged and the precipitate obtained
was washed thrice with ice cold 10% TCA. Then it was treated with 95% ethanol to
remove lipids. The final precipitate was heated at 90 C for 15 minutes with occasional
shaking, which facilitated the quantitative separation of nucleic acids from protein. The
supernatant after centrifugation was used for the estimation of DNA and RNA.
Deoxy ribonucleic acid (DNA)
DNA was estimated by the method of Burton (1956).[203]
Materials and Methods
87
Reagents
1. Diphenylamine reagent: 1.5 g diphenylamine was dissolved in 100 ml of
redistilled acetic acid and 1.5 ml of concentrated H2SO4 was added. The
reagent was stored at 4 C in dark. Before use, 0.1 ml of aqueous acetaldehyde
(0.16%) was mixed with every 20 ml of the reagent.
2. Stock standard: Highly polymerised calf-thymus DNA was dissolved in
5 mMNaOH to give a concentration of 0.4 mg/ml.
3. Working standard: This was prepared by mixing 2.0 ml of the stock solution
with an equal volume of 1 N perchloric acid and was heated at 70 C for 15
minutes.
Procedure
A known volume of the nucleic acid extract was made up to 3.0 ml with 1 N
perchloric acid. This was mixed with 2.0 ml of diphenylamine reagent. A reagent blank
and standards were also run out concurrently. This mixture was kept in a boiling water
bath for 10 minutes and the blue colourdeveloped was read at 640 nm in a
photochemcolorimeter.The amount of DNA was expressed as mg/g wet tissue.
Ribonucleic acid (RNA)
RNA was estimated by the method of Rawalet al. (1977).[204]
Reagents
1. Orcinol-ferric chloride reagent: One gram of orcinol was dissolved in 100 ml
of concentrated HCl containing 0.5 g of ferric chloride. This reagent was
prepared freshly.
Materials and Methods
88
2. Standard: Standard was prepared by dissolving 2.0 mg of yeast RNA in 100
ml of 5% TCA.
Procedure
Aliquots of nucleic acid extracts were made up to 2.0 ml with 5% TCA. To this
3.0 ml of orcinol-ferric chloride reagent was added and mixed well. The tubes were
heated in a boiling water bath for 20 minutes. Reagent blank and standards were also
treated in the same way. The tubes were cooled and the colour developed was
measured at 640 nm using a photochemcolorimeter.The RNA level was expressed as
mg/g wet tissue.
Statistical analysis
Statistical analysis was done by using Graph Pad INSTAT-V3 Version
computer software programme. Values are mean ± SEM for six animals in each
group and the significance of difference between mean values were determined by
one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison
test.
5.7. Isolation and characterization of the active principle of P. Polyphyllus
5.7.1. Isolation of compound I
The concentrate of the methanol extract of P. polyphyllus was fractionated
using benzene (3 300 ml), chloroform (3 300 ml) and ethyl acetate (4 300 ml).
The chloroform fraction on concentration yielded a brownish solid, which was non
homogenous in TLC and hence was further subjected to separation and purification
on column chromatography.[205,206]
Materials and Methods
89
Column chromatographic analysis
The residue obtained from the chloroform fraction (15g) of P. polyphyllus
was chromatographed in silica gel column (60-120 mesh, 300 gm, 100 5 cm) using
gradient elution with the solvents of increasing polarity. Fractions of 100 ml were
collected each time and the homogeneity was examined on TLC with suitable
solvents. The details of the fractionations and their characteristics are given in Table
27.
Fractions 1-5, 6-13, 14-31, 32-53,54-77, 78-82 and 83-95 each of which on
concentration yielded residues with varying intensities of green colour. These were
tested individually by TLC and further purification was not carried out because of
paucity of the samples. Fractions 83-95 on concentration yielded a pure brownish
homogeneous solid and were designated as compound I.
FT-IR Spectral data of compound I [207]
The FTIR spectrum of compound I was recorded using JASCO- FTIR 5300
spectrometer (Plate 1) using CDCl3 as the solvent and complete assignment of band
regions are shown in table 28.
1H-NMR Spectral data of compound I[208, 209]
The 1H-NMR spectrum of compound I was recorded using AMX 400 (400
MHz) spectrometer (Plate 2) using CDCl3 as the solvent and complete assignment of
protons are shown in table 29.
13C-NMR spectral data of compound I[208, 209]
13C-NMR spectrum of compound I was recorded using AMX 400 (100
MHz) spectrometer (Plate 3)using CDCl3 as the solvent and the complete
assignment of carbon are given in table 30.
Materials and Methods
90
LC-MS study of compound I [210]
LC-MS 2010 spectrum (Shimadzu) of compoundI(Plate 4) was taken and it
gave various fragments at m/z: (M) + 638
5. 7. 2. IsolationandCharacterisationofthe Active Principle fro ProsopisCineraria
Isolation of compound II
The concentrate of the methanol extract of ProsopisCinerariawas
fractionated using benzene (3 300 ml), diethyl ether (3 300 ml) and ethyl
acetate (4 300 ml). The ethyl acetate fraction on concentration yielded a yellow
solid, which was non homogenous in TLC and hence was further subjected to
separation and purification on column chromatography. [205,206]
Column chromatographic analysis
The residue obtained from the ethyl acetate fraction (15g) of
ProsopisCinerariawas chromatographed in silica gel column (60-120 mesh, 300
gm, 100 5 cm) using gradient elution with the solvents of increasing polarity.
Fractions of 100 ml were collected each time and the homogenity was examined on
TLC with suitable solvents. The details of the fractionations and their
characteristics are given in table 31.
Fractions 1-5, 6-10, 11-48, 49-64 and 65-76 each of which on concentration
yielded residues with varying intensities of yellow colour. These were tested
individually by TLC and further purification was not carried out because of paucity
of the samples. Fractions 77-90 on concentration yielded a pure yellowish
homogeneous solid and were designated as compound II. It gave dark green
colouration with neutral ferric chloride and violet colouration with
Materials and Methods
91
Molish’sreagent.TheRf values of compound II in various solvent systems are given
in table32.
Acid hydrolysis of compound II [212]
In order to find out the nature of the glycoside, compound II was subjected to
acid hydrolysis. To a solution of the glycoside (10 mg) in hot methanol (10 ml), an
equal volume of H2 SO4 (7%) was added and the mixture was gently refluxed at
100 C for 2 hours. The excess of alcohol was distilled off invacuoand the resulting
aqueous solution was partitioned with ether to separate the ether soluble aglycone
and the aqueous sugar.
Identification of the sugar [213]
The aqueous layer was treated with BaCO3 to remove excess sulphuric acid
and the barium sulphate formed was filtered off using Whatman No. 42 filter paper
and the filtrate (sugar portion) was concentrated.The concentrate was analyzed by
Paper chromatography (PC) with various authentic sugar samples on a Whatman
No.1 filter paper strip and identified using Aniline hydrogen phthalate spray reagent
(prepared by dissolving 9.2 ml of aniline and 16 g of phthalic acid in 490 ml of n-
butanol, 490 ml of ether and 20 ml of water). The various solvent systems used for
PC and Rf values of the identified sugar.in these solvent systems are presented in
table 33.
UV spectral characteristics of compound II [214]
Basic flavonoid structure of compound II and position of attachment of
hydroxyl group and other substituents were conveniently studied by recording UV
spectrophotometer (Shimadzu 1601) in MeOH as well as in various Shift reagents
shown in table 34..
Materials and Methods
92
1H-NMR Spectral data of compound II [208, 209]
The 1H-NMR spectrum of compound II was recorded using AMX 400 (400
MHz) spectrometer (Plate 1) using DMSO-d6 as the solvent and complete
assignment of protons are shown in table 35.
13C-NMR spectral data of compound II [208, 209]
13C-NMR spectrum of compound II was recorded using AMX 400 (100
MHz) spectrometer (Plate 2)using DMSO-d6 as the solvent and the complete
assignment of carbon are given in table 36.
EI-MS study of compound II [215]
EI-MS spectrum (Fenniganmat 8230, 70 eV) of compoundII (Plate 3) was
taken and it gave various fragments at m/z: 330, 213 and 118.
5.8. Cytotoxicity studies of Compounds I & II
The cytotoxicity studies of compound I & II on HepG2 - Human Liver
Cancer cells exactly in the same way as per described MTT assay method and
Hoechst staining and photomicroscopy [Apoptosis] in the Chapter 5.3.2. and
5.3.3.; Page No ----------.
top related